remain elevated for years after the specific insult (19, 20, 27) , cumulative exposure to AFB1 could potentially be measured.
Molecular biomarkers are becoming increasingly important
Further, the HPRT mutant T lymphocyte assays are welltools to identify people who are at highest risk of developing developed methods for detecting in vivo somatic cell gene cancer. For many years we have been studying residents mutations in humans (26,28-30). of Qidong County, People's Republic of China, to examine AFB1 is a very potent mutagen and the in vitro mutational the combined impact of aflatoxin exposure with other risk spectrum of AFB1 in exon 3 of the human HPRT gene in B factors as contributors to the high liver cancer incidence lymphoblasts has been characterized. The mutational hotspot rates in this region. This study was conducted to determine induced by AFB1 in vitro in exon 3 of the native human the effects of aflatoxin exposure, as measured by serum HPRT gene was a GC→TA transversion at base 209, occurring aflatoxin-albumin adduct levels, on somatic mutation in 17% of AFB1-induced mutants (23). This information frequency in the human hypoxanthine guanine phosphoprovided a basis to study HPRT mutation frequency in a high ribosyl transferase gene (HPRT). Subjects were assigned AFB1 exposure area in Qidong County, People's Republic of as low or high according to a dichotomization around China (31), and we report for the first time a relationship the population mean of aflatoxin-albumin adducts. HPRT between HPRT mutation and AFB1 exposure. mutant frequency was determined in individuals by a T
The study was conducted in Daxin Township, a community cell clonal assay and the samples were categorized as low of~40 000 residents in Qidong County, where HCC causes or high according to mean values. Separate analyses were 10% of all adult deaths (31, 32) . The subjects were a healthy also conducted for the small set of hepatitis B virus surface sub-group of individuals screened for participation in a chemoantigen (HBsAg)-positive and the larger set of HBsAgprevention trial with oltipraz that has been described previously negative individuals, known risk factors for liver cancer.
(33,34). None of the study subjects in this investigation were An odds ratio of 19.3 (95% confidence interval 2.0, 183) active participants in the intervention trial but they had been was demonstrated for a high HPRT mutation frequency in deemed eligible for inclusion by an extensive physical and individuals with high aflatoxin exposure compared with medical examination. The overall study cohort comprised 90 those with low aflatoxin exposure. This association indicates Chinese men and women aged 40-65 of whom 42 were male that aflatoxin-induced DNA damage in T lymphocytes, and 48 were female. Ten milliliter blood samples were drawn assessed using the validated surrogate albumin adduct from the 90 participants into Leukoprep tubes. These samples markers, leads to increased mutations reflected as elevated were processed immediately to separate serum, red blood cells HPRT gene mutations. This cross-sectional study suggests and white blood cells. They were sent within 48 h from the the potential use of mutation frequency of the HPRT gene time of collection on ice to the USA for analysis of HPRT as a long-term biomarker of aflatoxin exposure in high mutations. An additional 3 ml blood sample was drawn from risk populations.
the individuals for AFB1 analysis. analyzed a sample was blind to the identity of the subject. After receipt of the samples for assay for HPRT mutation, concentrators (Amicon, Beverly, MA). The amount of human serum albumin resulting from this process was determined in the tubes were centrifuged again and the mononuclear cell fraction was washed twice in medium (RPMI 1640) by each sample by a bromocresol purple dye binding method. Total serum proteins were then digested with Pronase prior to sedimentation, resuspended and frozen as described previously (29). For the cell cloning assay, the ampoules were thawed the measurement of AFB1 content by a radioimmunoassay. All statistical analyses were done using the statistical rapidly and the cell suspension added dropwise to 20 ml of RPMI 1640 containing 20% newborn bovine serum. After two package STATA. Of the 90 individuals for whom blood was collected, three washes by centrifugation, the cells were resuspended, counted, then diluted to 1ϫ10 6 cells/ml and incubated for 36-40 h with of the 42 males and six of the 48 females were HBsAg seropositive. The ages of the cohort ranged from 40 to 65 1 µg/ml phytohemagglutin (PHA). Following centrifigation and washing the cells were inoculated at 1, 2, 5 or 10 cells/ years of age and the average age (ϮSD) was 50.9 (Ϯ7.3) years for the males and 49.6 (Ϯ6.3) years for the females. well (non-selection) and 1 or 2ϫ10 4 cells/well (selection) into microtiter plates. Growth medium consisted of RPMI 1640
The average AFB1 measurement was 0.66 pmol AFB1/mg albumin and ranged from 0.27 to 1.19 pmol AFB1/mg albumin. medium containing 5% defined supplemented bovine calf serum (Sterile Systems, Grand Rapids, MI), 20% HL-1 medium
Tests of hematology and blood chemistry, urinalysis and a liver function test gave no indications of hematological, renal (Ventrex, Ventura, CA), 25 mM HEPES, 2 mM L-glutamine, 100 U/ml penicillin, 10 µg/ml streptomycin sulfate and optimal or liver disease. The clonal efficiencies were extremely low for the HPRT T lymphocyte cloning assay (4.0%). Due to amounts of T cell growth factor and 0.125 µg/ml PHA. Selection wells contained 10 -5 M 6-thioguanine (6-TG). Wells difficulty in the T cell cloning assay, many of the mutant frequencies (mutant frequency per clonable T cell) were not also contained 1ϫ10 4 irradiated (8000 rad) TK6 lymphoblastoid feeder cells, all in a total volume of 0.2 ml. Cells were able to be determined, significantly reducing the sample size. Despite the smaller sample size of 34, the data maintain their incubated for 10-14 days and scored for colony growth by use of an inverted phase microscope.
robustness and statistical validity when variables known to be unassociated with mutant frequency are examined. The odds Cloning efficiencies (non-selection and 6-TG selection) were calculated by the Poisson relationship P o ϭ e -x , which defines ratios for liver function (SGPT), white blood cells, hemoglobin and platelets with mutant frequency are consistent with tight the average number of clonable cells/well (x), and factored by the number of cells added to wells. The cloning efficiency in confidence intervals (Table I) . Prior research has indicated the need to adjust HPRT mutant selection divided by the non-selected cloning efficiency defines the measured mutant frequency reported as the frequency of frequency values for age and cloning efficiency (29, (35) (36) (37) and the values shown have been adjusted. Mutant frequencies 6-TG-resistant cells per 1 000 000 cells analyzed. Clones were also expanded for molecular analysis in modified RPMI 1640
were dichotomized for subsequent analysis based on the mean of the entire population (26.3ϫ10 -6 mutants/T cell) (Table I) . containing feeder cells (2.5ϫ10 5 cells/cm 2 ) in increasingly larger size wells.
Neither age nor gender was associated with HPRT mutant frequency. The human serum samples were assayed for the detection of AFB1-albumin adducts by methods that have been described AFB1 was dichotomized based on the mean of the population (0.66 pmol AFB1/mg albumin). Previous studies for AFB1 in detail (31) . Briefly. the samples were first concentrated by high speed centrifugal filtration using Microcon-50 microhave dichotomized exposure based on the mean of the popula-HPRT mutations after aflatoxin exposure internal stimuli causing the cells to undergo cell death or apoptosis (40, 41) . If the T cell viability was affected by the shipping conditions, then a selection bias on the remaining samples is not likely to have occurred. If T cell viability was due to heavily damaged cells, then the results would have been biased to one, as results from those with the most environmental damage would not have been obtained. For the remaining 34 samples, the range of mutant frequencies were consistent. Despite the difficulty in obtaining HPRT mutant frequencies and the final limited sample size, we believe that the mutant frequency values that were obtained are accurate and unbiased.
A major assumption in this study is that an individual's AFB1 measurement will be representative of the AFB1 exposure throughout their lives, even though AFB1-albumin adducts indicate recent exposure. Fortunately, the AFB1 measurements calculated in the study are comparable with the AFB1 measure- of low and high in this study are also consistent with that of previous studies.
Measurement of AFB1-albumin adducts is a valid method tion studied; the same has been done for this population. Since everyone in this population is exposed to some degree, to reliably and sensitively measure AFB1 exposure. Similarly, the T lymphocyte assay is the most reliable somatic mutation dichotomization allows stratification of this exposed population by those who have very high levels of exposure and those assay for measuring HPRT mutant frequencies. Furthermore, our population is well studied and their high exposures who have moderate to low exposures to AFB1. For those distinguished as low HPRT mutant frequencies, the mean to AFB1 lends itself to studying subsequent effects. The significantly positive odds ratio of 19.3 associating high AFB1 was 0.41 Ϯ 0.19 pmol AFB1/mg albumin. The mean AFB1 value for those with high mutant frequencies was 0.70 Ϯ AFB1-albumin adducts with high HPRT mutant frequencies is therefore consistent with the hypothesis that HPRT mutant 0.12 pmol AFB1/mg albumin. In Figure 1 , the relation between AFB1-albumin adduct levels and HPRT mutation frequency frequencies are a reflection of AFB1-induced DNA damage. A limitation to this study is the cross-sectional design. By for the individual samples are shown by the dotted lines representing the mean values for these measures. An association definition, a cause and effect relationship cannot be ascertained from a cross-sectional study; it is unknown whether the between AFB1 and HPRT mutant frequency was demonstrated with an odds ratio of 19.3 (95% confidence intervals 2.0, 183) exposure leads to the outcome or whether the outcome preceded the hypothesized exposure. In this case, however, biological for high mutant frequency in those with a high exposure to AFB1, compared with those with a low exposure to AFB1. plausibility indicates that AFB1 exposure leads to AFB1-albumin and AFB1-DNA adducts, which in turn lead to DNA This high risk population is exposed to a wide range of AFB1 levels (31) and it is suspected that only individuals with damage severe enough to be reported as HPRT gene mutations. The association between AFB1 and HPRT mutant frequency high levels of AFB1 exposure will develop DNA damage severe enough to be measured through reporter genes such as might be diluted due to exposure/AFB1 misclassification. It is likely that some individuals with high measurements at the the HPRT gene. The use of this study cohort increases the likelihood of identifying an association between AFB1 and time of blood collection are normally exposed at low levels and vice versa. The higher odds ratio associating AFB1 DNA mutations. That this cohort is also a high risk group for HCC (32,38,39) increases the possibility of detecting exposure and HPRT mutants (19.3) versus AFB1 exposure and HCC (usually~3.0) is expected. Even though most intermediate outcomes in the carcinogenic process such as mutations.
individuals in this population are exposed on some level to AFB1, only those with high levels of AFB1-albumin adducts The typical mutant frequency for normal healthy adults in the HPRT gene is 5-8ϫ10 -6 mutants/cell (22,23). The mean will lead to high mutant frequencies in the HPRT reporter gene and even though high AFB1 exposures were not compared mutation frequency for this population is 26.3ϫ10 -6 mutants/ cell. The significantly high mutant frequency indicates that with truly unexposed individuals, the association suggests that only high exposures and high albumin adduct levels are this population suffers from exposure to environmental agents that lead to DNA damage. In this study, mutant frequencies associated with subsequent DNA damage severe enough to be reported by the HPRT gene. After all, not all individuals with of only 34 of 90 individuals were able to be analyzed for all markers. Thirty-six of the individuals had T cells which were AFB1 exposure as measured by AFB1 adducts will develop HCC. Therefore, not all individuals with AFB1 adducts will not viable and could not be stimulated. An additional 20 individuals had T cells that were viable, but subsequent mutants manifest long-term DNA damage as increased HPRT mutations. HPRT isolated from T cells allows the reporting of were not able to be cloned. It is possible that shipping conditions and time taken to deliver the samples from China such damage due to its lower capacity for repair and the longer half-life. Finally, the lack of association between HBsAg to Vermont may have affected the ultimate viability of the T cells. Equally likely, however, is that the individuals' blood and HPRT mutant frequency further supports the association between AFB1 exposure and HPRT mutant frequency. If HPRT samples reflect that of a population exposed to damaging environmental exposures that lead to appropriate external or mutant frequency is demonstrated to be associated with HCC, 
